{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Indelicare%20DBA%20INKEEZE","name":"Indelicare DBA INKEEZE","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-04T06:40:34.629Z"},"count":1,"matches":[{"id":"36bb7c9e5533ac7f","posted_date":"2024-03-26","letter_issue_date":"2024-03-25","company_name":"Indelicare DBA INKEEZE","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Finished Pharmaceuticals/Unapproved New Drug/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/36bb7c9e5533ac7f"}]}